"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
about
Omalizumab for asthma in adults and childrenA review of omalizumab for the management of severe asthmaTreating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a reviewEffectiveness of omalizumab in severe persistent asthma under real-life conditions.Novel diagnostic approaches and biological therapeutics for intrinsic asthma.Omalizumab in the treatment of asthma.Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry.Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting.Long-term benefits of omalizumab in a patient with severe non-allergic asthmaOmalizumab, an anti-immunoglobulin E antibody: state of the art.Update on optimal use of omalizumab in management of asthma.Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience.Omalizumab: clinical use for the management of asthma.Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.Therapeutic options for severe asthmaEffectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world studyImpact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting.Severe asthma and fungi: current evidence.Severe asthma with fungal sensitization.Omalizumab: a review of its use in patients with severe persistent allergic asthma.Fungus-associated asthma: overcoming challenges in diagnosis and treatment.The discovery and development of omalizumab for the treatment of asthma.Omalizumab therapy for children and adolescents with severe allergic asthma.Appropriate selection for omalizumab treatment in patients with severe asthma?4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry.'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review.Targeted Therapy for Older Patients with Uncontrolled Severe Asthma: Current and Future Prospects.Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.Biologic therapy in the management of asthma.Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma.Advances in anti-IgE therapyOmalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study.The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma.Quality of life among hazardous and harmful drinkers: EQ-5D over a 1-year follow-up period.Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.Overlapping Effects of New Monoclonal Antibodies for Severe Asthma.Cost-effectiveness of omalizumab in severe persistent asthma in Spain: a real-life perspective.
P2860
Q24201145-A926E839-CE33-4725-962B-9A35488C220FQ26741315-D76543EE-B56B-4DE9-BDB7-1A94B674FA66Q30801642-A762663F-872E-436A-9F39-BD398FFE9E26Q33894739-9F3779C0-205F-4CA2-9B54-50B8164BC370Q33904534-82CC59CD-5F00-44E8-9FAA-B0D099B2C442Q34029374-54DE9FF5-50ED-449B-B9FB-0153C0A8DD3DQ34324456-88C6A84A-D87F-40F2-86E3-DA1B9AD4E3A6Q34627039-E91AF57F-E628-4079-BEE5-CADB82A972D6Q35078215-1481A7B2-7685-429C-975A-B0955A969E51Q35095218-0959BF14-EFDA-4AA0-9906-076062D0B257Q35117827-FB6F5576-D097-4F97-9978-2996FD4542EDQ36000022-4D764B2D-991E-43FA-A747-1C3D2F37BD20Q36055963-70BB9186-D1C0-4FAC-8EF6-005319C6C07BQ36113704-3D95E0F0-320F-4B09-A957-CD330A83503DQ36286252-A10C311C-FFFC-4541-B5A7-E3BFD859B3CAQ36924944-259E01E3-DD26-49FC-A030-92FABFCA8F65Q37177646-223D312E-4149-48D3-A94C-505270E2BFBCQ37428213-38E6C94D-48DC-43FF-A8C1-2134A3B14B4DQ37775970-5E5F6B99-B34B-4669-8249-488EFAEE2BDDQ37905686-7E834413-AEF2-443E-BDF0-1DE6C050B77FQ38118172-37D507C1-785B-423B-BF4D-E7C85197498EQ38192062-689C1739-9FAB-4DF7-A0EC-8FB20E27203AQ38483005-EC2ABFFE-1C6A-434C-95F2-52E38A29B623Q38574776-B4C159E2-72CB-48BC-A056-DD406048C1A4Q38621259-CBE5FF0D-0E5C-4517-9C1F-FBCEC6B1663FQ38645546-100C5CA2-57A4-452B-9F86-F5E68B989C86Q38661772-94BD10C0-7D84-4F4C-B6B2-4D5F78EFFBD2Q38820261-0736394F-AAF7-43FD-B509-169EBA5415B7Q38824499-CC8AE4FC-845A-42C0-8AB6-7B669F1B9582Q38846809-9C13C813-4347-43AD-A3B2-CF662609CA6EQ38982481-C677D15E-07B8-479C-982D-F3C197A6FE45Q40812061-68FFF2B5-CC6A-4501-9CA2-638FD5A3936FQ40889826-AF1E0C0A-D628-4A80-872F-34FABF54A29FQ41577766-DE0688DE-BFBB-4E1B-91A7-81C8DFD45BAAQ42693253-8513F840-355C-43D8-BB51-BBB3E8427BFCQ43873984-D4D532C2-E708-472C-821C-C9E6CF7EB832Q46195557-D5D82E29-704E-443D-95EB-ED0852880DDAQ46703592-B194A8E9-2763-4242-AE23-7CED3CD93E64Q47921576-0A6E3519-1E44-4B27-9B90-23BC63B647A2Q48071558-42523A9B-5B61-474A-ADE9-479A529062C9
P2860
"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@en
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@nl
type
label
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@en
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@nl
prefLabel
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@en
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@nl
P2093
P1433
P1476
"Real-life" effectiveness of o ...... gic asthma: The PERSIST study.
@en
P2093
B Van de Maele
G Brusselle
K MacDonald
P304
P356
10.1016/J.RMED.2009.06.014
P577
2009-07-19T00:00:00Z